CHENGDU RUITING CULTURE MEDIA CO., LTD. – Trademark Portfolio
Entity Type: 99
CHENGDU RUITING CULTURE MEDIA CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include YULKB, FTNOLF, and WODFUY. The owner is based in CHENGDU.
NO. 6, 4/F, BUILDING 4, NO. 51, SECTION 4
SOUTH SECOND RING RD., WUHOU DIST.,
CHENGDU 610000 , CN
Showing of trademarks Trademarks
Trademark Classifications
CHENGDU RUITING CULTURE MEDIA CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does CHENGDU RUITING CULTURE MEDIA CO., LTD. have?
CHENGDU RUITING CULTURE MEDIA CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does CHENGDU RUITING CULTURE MEDIA CO., LTD. file in?
CHENGDU RUITING CULTURE MEDIA CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 7 (Machinery). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are CHENGDU RUITING CULTURE MEDIA CO., LTD.'s most well-known trademarks?
CHENGDU RUITING CULTURE MEDIA CO., LTD.'s registered trademark portfolio includes well-known marks such as YULKB, FTNOLF, and WODFUY. These are among 3 currently registered trademarks in the portfolio.
What is CHENGDU RUITING CULTURE MEDIA CO., LTD.'s trademark registration success rate?
CHENGDU RUITING CULTURE MEDIA CO., LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.